Michael Messina to Tumor Suppressor Proteins
This is a "connection" page, showing publications Michael Messina has written about Tumor Suppressor Proteins.
Connection Strength
0.018
-
Lee N, Woodrum CL, Nobil AM, Rauktys AE, Messina MP, Dabora SL. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models. BMC Pharmacol. 2009 Apr 15; 9:8.
Score: 0.018